Currently out of the existing stock ratings of Brian Wright, 24 are a BUY (85.71%), 4 are a HOLD (14.29%).

Brian Wright

Work Performance Price Targets & Ratings Chart

Analyst Brian Wright, currently employed carries an average stock price target met ratio of 36% that have a potential upside of 14.72% achieved within 102 days.

Brian Wright’s has documented 56 price targets and ratings displayed on 10 stocks. The coverage was on Basic Materials, Industrials, Consumer Defensive sectors.

Most recent stock forecast was given on BIOX, Bioceres Crop Solutions Corp at 02-Jul-2024.

Wall Street Analyst Brian Wright

Analyst best performing recommendations are on EVGN (EVOGENE).
The best stock recommendation documented was for EVGN (EVOGENE) at 7/21/2023. The price target of $10 was fulfilled within 14 days with a profit of $1.3 (11.5%) receiving and performance score of 8.22.

Average potential price target upside

of $14.17 (32.08%) on CTVA (CORTEVA).
of $6.35 (4.96%) on LNN (LINDSAY).
of $5.81 (42.23%) on PAHC (PHIBRO ANIMAL HEALTH).

CTVA Corteva LNN Lindsay EVGN Evogene LOCL Local Bounti Corp ANDE The Andersons BIOX Bioceres Crop Solutions Corp PAHC Phibro Animal Health XXII 22nd Century Group ADM Archer-Daniels-Midland Company BG Bunge

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Arun Viswanathan (RBC)